Zydus Generics

Zydus Generics is a key pillar of Zydus Lifesciences’ global operations, focused on delivering high-quality, affordable medicines at scale across regulated and emerging markets. With a strong presence in the United States, Europe and other international markets, the business plays a critical role in expanding access to essential therapies worldwide.

Backed by integrated capabilities across the pharmaceutical value chain—from development and manufacturing to global supply—Zydus Generics offers a diverse portfolio spanning oral solids, injectables and complex generics. The business leverages robust research and manufacturing infrastructure to bring differentiated products to market, addressing a wide range of therapeutic areas.

Zydus has established a strong footprint in regulated markets, particularly in the US, supported by a consistent pipeline of product approvals and launches. This enables the Company to deliver value through quality, reliability and scale, while responding to evolving healthcare needs.

Aligned with Zydus’ broader purpose of empowering lives through science and innovation, the generics business continues to enhance affordability and accessibility of therapies. By combining operational excellence with a global reach, Zydus Generics plays a vital role in improving healthcare outcomes and ensuring wider access to medicines across geographies.

All Products (242)
Product Name
Acefex Forte Tab
Acefex P Tab (Alu- Alu & Blister Pack)
Activa Inj. ( 3ml / 30 Ml. )
Activa Mr Tab
Activa – S Tab
Activa Gel
Activa Sr Tab.
Alermed -120 Tab
Alpracad Tab ( 0.25 Mg / 0.5 Mg )
Amee Inj. (100 Mg / 250 Mg / 500 Mg )
1-10 of 242 Products are Showing